Overuse of organ biopsies in immunoglobulin light chain amyloidosis (AL): the consequence of failure of early recognition

Annals of Medicine

Volumn 49, Issue 7, 2017, Pages 545-551

  Muchtar, Eli ^a   Dispenzieri, Angela ^a   Lacy, Martha Q ^a   Buadi, Francis K ^a   Kapoor, Prashant ^a   Hayman, Suzanne R ^a   Gonsalves, Wilson ^a   Warsame, Rahma ^a   Kourelis, Taxiarchis V ^a   Chakraborty, Rajshekhar ^a,b   Russell, Stephen ^a   Lust, John A ^a   Lin, Yi ^a   Go, Ronald S ^a   Zeldenrust, Steven ^a   Rajkumar, S Vincent ^a   Dingli, David ^a   Leung, Nelson ^a   Kyle, Robert A ^a   Kumar, Shaji K ^a   Gertz, Morie A ^a   more..

^a MAYO CLINIC   (United States)

^b Essentia Health St Joseph s Hospital   (United States)

Author keywords

apple green; biopsy; Congo red; histopathology; organ

Indexed keywords

CONGO RED; FAT; IMMUNOGLOBULIN LIGHT CHAIN; COLORING AGENT;

ADULT; AGED; AL AMYLOIDOSIS; ARTICLE; BIOPSY; BONE MARROW BIOPSY; FEMALE; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SEX DIFFERENCE; ADIPOSE TISSUE; BONE MARROW; CARDIAC MUSCLE; CHEMISTRY; KIDNEY; LIVER; MIDDLE AGED; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; SEX FACTOR; STAINING; UTILIZATION;

ADIPOSE TISSUE; AGED; BIOPSY; BONE MARROW; COLORING AGENTS; CONGO RED; FEMALE; HUMANS; IMMUNOGLOBULIN LIGHT-CHAIN AMYLOIDOSIS; KIDNEY; LIVER; MALE; MIDDLE AGED; MYOCARDIUM; RETROSPECTIVE STUDIES; SEX FACTORS; STAINING AND LABELING;

EID: 85016103126     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.1080/07853890.2017.1304649     Document Type: Article

References (21)

1. Muchtar E, Buadi FK, Dispenzieri A, et al. Immunoglobulin light-chain amyloidosis: from basics to new developments in diagnosis, prognosis and therapy. Acta Haematol. 2016;135:172–190.
2. Gertz MA, Lacy MQ, Dispenzieri A, et al. Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report. Leuk Lymphoma. 2010;51:2181–2187.
3. Kyle RA, Gertz MA., Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol. 1995;32:45–59.
4. Miyazaki K, Kawai S, Suzuki K., Abdominal subcutaneous fat pad aspiration and bone marrow examination for the diagnosis of AL amyloidosis: the reliability of immunohistochemistry. Int J Hematol. 2015;102:289–295.
5. Deckers JW, Hare JM, Baughman KL., Complications of transvenous right ventricular endomyocardial biopsy in adult patients with cardiomyopathy: a seven-year survey of 546 consecutive diagnostic procedures in a tertiary referral center. J Am Coll Cardiol. 1992;19:43–47.
6. Holzmann M, Nicko A, Kühl U, et al. Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period. Circulation. 2008;118:1722–1728.
7. Tondel C, Vikse BE, Bostad L, et al. Safety and complications of percutaneous kidney biopsies in 715 children and 8573 adults in Norway 1988–2010. Clin J Am Soc Nephrol. 2012;7:1591–1597.
8. Foli A, Palladini G, Caporali R, et al. The role of minor salivary gland biopsy in the diagnosis of systemic amyloidosis: results of a prospective study in 62 patients. Amyloid. 2011;18:80–82.
9. van Gameren II, Hazenberg BP, Bijzet J, et al. Diagnostic accuracy of subcutaneous abdominal fat tissue aspiration for detecting systemic amyloidosis and its utility in clinical practice. Arthritis Rheum. 2006;54:2015–2021.
10. Gertz MA, Li CY, Shirahama T, et al. Utility of subcutaneous fat aspiration for the diagnosis of systemic amyloidosis (immunoglobulin light chain). Arch Intern Med. 1988;148:929–933.
11. Gertz MA, Comenzo R, Falk RH, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18–22 April 2004. Am J Hematol. 2005;79:319–328.
12. Lousada I, Comenzo RL, Landau H, et al. Light chain amyloidosis: patient experience survey from the amyloidosis research consortium. Adv Ther. 2015;32:920–928.
13. Haas M, Meehan SM, Karrison TG, et al. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976–1979 and 1995–1997. Am J Kidney Dis. 1997;30:621–631.
14. Bergesio F, Ciciani AM, Santostefano M, et al. Renal involvement in systemic amyloidosis–an Italian retrospective study on epidemiological and clinical data at diagnosis. Nephrol Dial Transplant. 2007;22:1608–1618.
15. Fernandez de Larrea C, Verga L, Morbini P, et al. A practical approach to the diagnosis of systemic amyloidoses. Blood. 2015;125:2239–2244.
16. van Gameren II, Hazenberg BP, Bijzet J, et al. Amyloid load in fat tissue reflects disease severity and predicts survival in amyloidosis. Arthritis Care Res (Hoboken). 2010;62:296–301.
17. Devata S, Hari P, Markelova N, et al. Detection of amyloid in abdominal fat pad aspirates in early amyloidosis: Role of electron microscopy and Congo red stained cell block sections. Cytojournal. 2011;8:11.
18. Guy CD, Jones CK., Abdominal fat pad aspiration biopsy for tissue confirmation of systemic amyloidosis: specificity, positive predictive value, and diagnostic pitfalls. Diagn Cytopathol. 2001;24:181–185.
19. Bogov B, Lubomirova M, Kiperova B., Biopsy of subcutaneus fatty tissue for diagnosis of systemic amyloidosis. Hippokratia. 2008;12:236–239.
20. Guidelli GM, Bardelli M, Selvi E, et al. Punch biopsy for fat tissue collection in amyloidosis: is it time to stop needle aspiration? Rheumatology (Oxford). 2015;54:2109–2111.
21. Suzuki T, Kusumoto S, Yamashita T, et al. Labial salivary gland biopsy for diagnosing immunoglobulin light chain amyloidosis: a retrospective analysis. Ann Hematol. 2016;95:279–285.